Clinical trial
Study of Thiotepa Combination With Melphalan (TM Protocol) Conditioning for Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma：A Prospective Randomized Controlled Clinical Trial
NCT07542418 is registered in ClinicalTrials.gov with First Affiliated Hospital Xi'an Jiaotong University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of Thiotepa Combination With Melphalan (TM Protocol) Conditioning for Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma：A Prospective Randomized Controlled Clinical Trial
- Lead sponsor
- First Affiliated Hospital Xi'an Jiaotong University
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- April 20, 2026
- Completion date
- October 20, 2028
- Enrollment
- 204 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.